Your browser doesn't support javascript.
loading
CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia.
Zhou, Huarong; Jia, Bei; Annageldiyev, Charyguly; Minagawa, Kentaro; Zhao, Chenchen; Mineishi, Shin; Ehmann, W Christopher; Naik, Seema G; Cioccio, Joseph; Wirk, Baldeep; Songdej, Natthapol; Rakszawski, Kevin L; Nickolich, Myles S; Shen, Jianzhen; Zheng, Hong.
Afiliação
  • Zhou H; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Jia B; Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fujian Medical Center of Hematology, Fuzhou, China.
  • Annageldiyev C; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Minagawa K; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Zhao C; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Mineishi S; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Ehmann WC; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Naik SG; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Cioccio J; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Wirk B; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Songdej N; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Rakszawski KL; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Nickolich MS; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Shen J; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, United States.
  • Zheng H; Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fujian Medical Center of Hematology, Fuzhou, China.
Front Immunol ; 14: 1169144, 2023.
Article em En | MEDLINE | ID: mdl-37457737
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article